CYRX Overview

Cryoport, Inc. is a provider of integrated, temperature-controlled supply chain solutions for the life sciences. The Company operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.

Wall Street analysts forecast CYRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CYRX is11.00 USD with a low forecast of 11.00 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Cryoport Inc revenue for the last quarter amounts to 45.45M USD, increased 9.64

Cryoport Inc. EPS for the last quarter amounts to -0.27 USD, decreased -35.71

Cryoport Inc (CYRX) has 684 emplpoyees as of April 13 2026.

Today CYRX has the market capitalization of 482.11M USD.